In this Friday’s PCT Grand Rounds, Stefan James and Jonas Oldgren of Uppsala University will present “DAPA-MI – A Pragmatic Registry-Based Double-Blind RCT Trial Designed for Regulatory Evaluation.”
The Grand Rounds session will be held on Friday, June 14, 2024, at 1:00 pm eastern.
DAPA-MI (Dapagliflozin in Patients With MI) was a registry-based, placebo-controlled trial of dapagliflozin in patients hospitalized for myocardial infarction and with impaired left ventricular function without known diabetes or established heart failure. James and Oldgren are professors of cardiology in the Department of Medical Sciences and the Uppsala Clinical Research Center at Uppsala University.